ATE122659T1 - Pyridinylcarbonylaminoalkyl-dihydro-oxo-pyridin , ihr verfahren zur herstellung und ihre verwendung. - Google Patents
Pyridinylcarbonylaminoalkyl-dihydro-oxo-pyridin , ihr verfahren zur herstellung und ihre verwendung.Info
- Publication number
- ATE122659T1 ATE122659T1 AT93102220T AT93102220T ATE122659T1 AT E122659 T1 ATE122659 T1 AT E122659T1 AT 93102220 T AT93102220 T AT 93102220T AT 93102220 T AT93102220 T AT 93102220T AT E122659 T1 ATE122659 T1 AT E122659T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- disturbances
- hydrogen
- compounds
- loweralkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92102828 | 1992-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE122659T1 true ATE122659T1 (de) | 1995-06-15 |
Family
ID=8209352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93102220T ATE122659T1 (de) | 1992-02-20 | 1993-02-12 | Pyridinylcarbonylaminoalkyl-dihydro-oxo-pyridin , ihr verfahren zur herstellung und ihre verwendung. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5360808A (en10) |
EP (1) | EP0556738B1 (en10) |
JP (1) | JPH069560A (en10) |
KR (1) | KR930017895A (en10) |
CN (1) | CN1075480A (en10) |
AT (1) | ATE122659T1 (en10) |
AU (1) | AU3375993A (en10) |
CA (1) | CA2089955A1 (en10) |
CZ (1) | CZ403592A3 (en10) |
DE (1) | DE69300152D1 (en10) |
FI (1) | FI930716A (en10) |
HU (1) | HU9300463D0 (en10) |
IL (1) | IL104781A0 (en10) |
MA (1) | MA22806A1 (en10) |
MX (1) | MX9300915A (en10) |
NO (1) | NO930594L (en10) |
ZA (1) | ZA931185B (en10) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02006131A (es) * | 1999-12-21 | 2002-12-16 | Monsanto Technology Llc | Derivados de diacilo herbicidas de propilendiamina. |
DE10205219A1 (de) * | 2002-02-08 | 2003-08-21 | Bayer Ag | Chinoxalinone und ihre Verwendung |
US6869966B2 (en) * | 2002-09-30 | 2005-03-22 | Banyu Pharmaceutical Co., Ltd. | N-substituted-2-oxodihydropyridine derivatives |
US20040127129A1 (en) * | 2002-12-31 | 2004-07-01 | Shuiyuan Luo | Grooved-shape monofilaments and the fabrics made thereof |
US8138209B2 (en) * | 2005-07-13 | 2012-03-20 | Jenrin Discovery, Inc. | Substituted picolinamides as MAO-B inhibitors useful for treating obesity |
US8314087B2 (en) | 2007-02-16 | 2012-11-20 | Amgen Inc. | Nitrogen-containing heterocyclyl ketones and methods of use |
KR101370185B1 (ko) | 2008-12-23 | 2014-03-05 | 에프. 호프만-라 로슈 아게 | P2x7 조절제로서의 디히드로피리돈 아미드 |
CA2745866A1 (en) | 2008-12-23 | 2010-07-01 | F.Hoffmann-La Roche Ag | Dihydropyridone ureas as p2x7 modulators |
WO2010072597A1 (en) | 2008-12-23 | 2010-07-01 | F. Hoffmann-La Roche Ag | Dihydropyridone amides as p2x7 modulators |
WO2010072605A1 (en) | 2008-12-23 | 2010-07-01 | F. Hoffmann-La Roche Ag | Dihydropyridone amides as p2x7 modulators |
US8153808B2 (en) | 2008-12-23 | 2012-04-10 | Roche Palo Alto Llc | Dihydropyridone amides as P2X7 modulators |
US8816085B2 (en) | 2009-08-26 | 2014-08-26 | Takeda Gmbh | Methylpyrrolopyridinecarboxamides |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2637477A1 (de) * | 1976-08-20 | 1978-02-23 | Hoechst Ag | Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung |
US4297360A (en) * | 1980-03-28 | 1981-10-27 | Sterling Drug Inc. | 5-(Pyridinyl)pyridine-2,3-diamines, preparation thereof and their cardiotonic use |
NZ195564A (en) * | 1979-11-26 | 1983-09-30 | Sterling Drug Inc | 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds |
IT8367883A0 (it) * | 1982-08-23 | 1983-08-22 | Rorer Int Overseas | Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche |
GB8809481D0 (en) * | 1988-04-21 | 1988-05-25 | Smith Kline French Lab | Chemical compounds |
-
1992
- 1992-12-31 CZ CS924035A patent/CZ403592A3/cs unknown
-
1993
- 1993-02-12 DE DE69300152T patent/DE69300152D1/de not_active Expired - Lifetime
- 1993-02-12 AT AT93102220T patent/ATE122659T1/de not_active IP Right Cessation
- 1993-02-12 EP EP93102220A patent/EP0556738B1/en not_active Expired - Lifetime
- 1993-02-18 US US08/019,296 patent/US5360808A/en not_active Expired - Fee Related
- 1993-02-18 KR KR1019930002218A patent/KR930017895A/ko not_active Application Discontinuation
- 1993-02-18 IL IL104781A patent/IL104781A0/xx unknown
- 1993-02-18 FI FI930716A patent/FI930716A/fi not_active Application Discontinuation
- 1993-02-19 ZA ZA931185A patent/ZA931185B/xx unknown
- 1993-02-19 CA CA002089955A patent/CA2089955A1/en not_active Abandoned
- 1993-02-19 AU AU33759/93A patent/AU3375993A/en not_active Abandoned
- 1993-02-19 CN CN93101816A patent/CN1075480A/zh active Pending
- 1993-02-19 HU HU9300463A patent/HU9300463D0/hu unknown
- 1993-02-19 MA MA23099A patent/MA22806A1/fr unknown
- 1993-02-19 MX MX9300915A patent/MX9300915A/es unknown
- 1993-02-19 JP JP5029515A patent/JPH069560A/ja active Pending
- 1993-02-19 NO NO93930594A patent/NO930594L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CZ403592A3 (en) | 1993-12-15 |
EP0556738B1 (en) | 1995-05-17 |
IL104781A0 (en) | 1993-06-10 |
NO930594L (no) | 1993-08-23 |
KR930017895A (ko) | 1993-09-20 |
AU3375993A (en) | 1993-08-26 |
JPH069560A (ja) | 1994-01-18 |
MA22806A1 (fr) | 1993-10-01 |
ZA931185B (en) | 1993-09-16 |
EP0556738A1 (en) | 1993-08-25 |
NO930594D0 (no) | 1993-02-19 |
US5360808A (en) | 1994-11-01 |
HU9300463D0 (en) | 1993-05-28 |
CA2089955A1 (en) | 1993-08-21 |
CN1075480A (zh) | 1993-08-25 |
FI930716A (fi) | 1993-08-21 |
DE69300152D1 (de) | 1995-06-22 |
FI930716A0 (fi) | 1993-02-18 |
MX9300915A (es) | 1993-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE122659T1 (de) | Pyridinylcarbonylaminoalkyl-dihydro-oxo-pyridin , ihr verfahren zur herstellung und ihre verwendung. | |
SE8801807D0 (sv) | New benzo(b)pyranes and pyranopyridines, process for their production and their use | |
PH31123A (en) | Benzimidazole compounds. | |
JPS60208987A (ja) | ピリドベンゾチアジン誘導体の製造法 | |
ATE140920T1 (de) | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung | |
JP2007508373A (ja) | 新規な化合物 | |
US5145850A (en) | Imidazopyridazines, their production and use | |
ATE123492T1 (de) | Benzocycloalkylaminopyridinamine und verwandte verbindungen, verfahren zu ihrer herstellung, zwischenverbindungen und ihre verwendung als arzneimittel. | |
US5132305A (en) | Benzoxazolinone compounds, compositions and use | |
ATE303453T1 (de) | Verfahren zur herstellung eines kalt gewalzten bandes oder bleches aus stahl und nach dem verfahren herstellbares band oder blech | |
AU621388B2 (en) | The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages | |
ATE211136T1 (de) | Coumarin-derivate, verfahren zu deren herstellung und deren verwendung | |
HRP920948A2 (en) | Nitratoalkanecarbone acid derivatives, process for the preparation thereof, the use of the same and drugs containing them | |
ATE146176T1 (de) | Benzo(b)thiophen-3-yl-piperazine, verfahren zur deren herstellung und ihre verwendung als arzneimittel | |
DE69529958D1 (de) | Aminoalkyloxime, Verfahren zur dessen Herstellung, ihre Verwendung als Medikamente und Zwischenprodukte | |
DE68906647D1 (de) | Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel. | |
JPH04279577A (ja) | ホルスコリンの6−(置換アミノプロピオニル)−誘導体の製法 | |
JP4645779B2 (ja) | キノリンカルボアルデヒドの製造法 | |
JPH02172984A (ja) | クロマン誘導体 | |
Shutalev et al. | Synthesis and steric structure of 4-arylaminohexahydropyrimidine-2-thiones | |
JPH02270848A (ja) | 新規ジアミン化合物及びその製造法 | |
CH649087A5 (de) | 6-alpha-brompenicillansaeureester, ihre sulfoxide und sulfone. | |
JP3535565B2 (ja) | ベンゾピラン誘導体 | |
ATE28878T1 (de) | Neue 6alpha-methylprednisolon-derivate ihre herstellung und verwendung. | |
DE69521429D1 (de) | Pyroglutaminsäure derivate, verfahren zur herstellung und anwendungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REZ | Deleted due to withdrawal |